Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - OTHER FINANCING ACTIVITIES
Other Financing Activities ELVN - Enliven Therapeutics, Inc.
234 M
LAST VALUE
1280.71%
2 YEAR CAGR
104.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR